Second Propaedeutic Department of Medicine, Aristotle University, Thessaloniki, Greece.
VAMC and Georgetown University, School of Medicine, Washington, DC, United States.
Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835.
Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases worldwide, affecting more than 30% of general population. High-fat diets, physical inactivity and obesity, all prevalent in the western societies, are strongly associated with the development and progression of NAFLD. Current drug therapies have not consistently shown substantial beneficial effects. Thus, lifestyle modification appears to be the optimal intervention in combating the disease. Accordingly, several studies have concluded that weight loss, via increase in physical activity, and dietary interventions could potential ameliorate biochemical, histological, and structural abnormalities of non-alcoholic fatty liver disease. The aim of this review is to summarize the findings of these lifestyle intervention studies and discuss the implementation of each intervention, and its effectiveness in the management of the disease in everyday clinical practice.
非酒精性脂肪性肝病(NAFLD)是全球最常见的疾病之一,影响着超过 30%的普通人群。高脂肪饮食、缺乏身体活动和肥胖,这些在西方社会普遍存在的因素与 NAFLD 的发生和发展密切相关。目前的药物治疗并没有一致显示出显著的有益效果。因此,生活方式的改变似乎是对抗这种疾病的最佳干预措施。因此,有几项研究得出结论,通过增加身体活动和饮食干预来减肥,可以潜在地改善非酒精性脂肪性肝病的生化、组织学和结构异常。本文的目的是总结这些生活方式干预研究的结果,并讨论每种干预措施的实施及其在日常临床实践中治疗该疾病的有效性。